Screener
Arcus Biosciences RCUS Other Non-Current Assets
Other Non-Current Assets at other companies
Other financials
Where this comes from
Reported directly by Arcus Biosciences in its filing.
Tagged under the XBRL concept us-gaap:OtherAssetsNoncurrent.
The source filing: Arcus Biosciences’s 10-Q, filed August 5, 2026.
- Filed
- Aug 5, 2026, 4:11 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001724521-26-000044
| Line item | June 30,2026 | December 31,2025 |
|---|---|---|
| Total current assets | 756 | 1,007 |
| Long-term marketable securities | 73 | 29 |
| Property and equipment, net | 36 | 40 |
| Other noncurrent assets | 59 | 63 |
| Total assets | $924 | $1,139 |
| LIABILITIES AND STOCKHOLDERS' EQUITY | ||
| Current liabilities: | ||
| Accounts payable ($12 and $24 to a related party) | $34 | $42 |
Item 1. Financial Statements
FAQ
- What is Arcus Biosciences's other non-current assets?
- Arcus Biosciences (RCUS) reported other non-current assets of $59M in Q2 2026.
- How has Arcus Biosciences's other non-current assets changed year-over-year?
- Arcus Biosciences's other non-current assets decreased by 14.5% year-over-year, from $69M to $59M.
- What is the long-term trend for Arcus Biosciences's other non-current assets?
- Over 5 years (2020 to 2025), Arcus Biosciences's other non-current assets has grown at a 58.8% compound annual growth rate (CAGR), from $6.25M to $63M.
- What does other non-current assets mean?
- Long-term assets not classified in specific categories — a catch-all for miscellaneous non-current assets.
Ask your AI about Arcus Biosciences's other non-current assets.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude